Role of bcl-2 mRNA in homeostatic proliferation in circulating T-cells in human liver transplant patients after T-cell depletion

J Surg Res. 2005 Aug;127(2):123-30. doi: 10.1016/j.jss.2005.03.008.

Abstract

Background: Prolonged T-cell depletion after liver transplantation leads to life-threatening infections. Members of the anti-apoptotic Bcl-2 gene family can maintain T-cell viability. T-cell numbers and their Bcl-2 expression following living donor liver transplantation (LDLT) were analyzed in 108 surviving and 13 deceased recipients.

Materials and methods: Bcl-2 mRNA levels and phenotypic changes of T-cells were examined by quantitative PCR and by measuring expression of CD45RO and CCR7.

Results: Based on the restoration of peripheral T-cell numbers, the 108 surviving recipients were classified into three groups. All recipients showed T-cell depletion, down to approximately 30% of pretransplant levels within 3 h of graft reperfusion. In Group I, the T-cell numbers were rapidly restored to pretransplant levels, within 5 days, with a rapid decrease in Bcl-2 mRNA levels immediately after LDLT. In Group II, the T-cell numbers were restored to normal levels by 19 days, with down-regulation of Bcl-2 mRNA. In Group III, the T-cell numbers were maintained at low levels for much longer, with high levels of Bcl-2 mRNA. In all three groups of recipients, there was statistically significant (r = -0.78) inverse correlation between T-cell numbers and Bcl-2 mRNA.

Conclusions: For successful transplantation, homeostatic restoration of T-cells must occur as soon as possible. Evaluation of peripheral T-cell numbers and of Bcl-2 expression may have therapeutic potential in identifying those transplant patients who face increased risk of infection.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adolescent
  • Adult
  • Blood Cells / pathology*
  • Child
  • Child, Preschool
  • Female
  • Homeostasis*
  • Humans
  • Infant
  • Infections / blood
  • Infections / etiology
  • Infections / mortality
  • Liver Transplantation* / adverse effects
  • Living Donors
  • Lymphocyte Count
  • Lymphocyte Depletion* / adverse effects
  • Male
  • Middle Aged
  • Postoperative Period
  • Proto-Oncogene Proteins c-bcl-2 / genetics*
  • RNA, Messenger / blood*
  • T-Lymphocytes / pathology*

Substances

  • Proto-Oncogene Proteins c-bcl-2
  • RNA, Messenger